focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Canada recommends AstraZeneca vaccine despite U.S. criticism of trial data

Tue, 23rd Mar 2021 17:33

(Updates with restrictions in Regina, Saskatchewan; high
schools reopening for daily class in Quebec)

By Steve Scherer

OTTAWA, March 23 (Reuters) - Canada on Tuesday said the
AstraZeneca COVID-19 vaccine is safe and will continue
to be recommended for use despite criticism from U.S. officials
of the drugmaker's analysis of the shot's efficacy in a large
trial, health officials said.

"The message is that the efficacy and the safety of the
vaccine have been shown," senior Health Canada official Marc
Berthiaume said. "It continues to be beneficial for Canadians to
prevent COVID-19."

Deliveries of coronavirus vaccines are ramping up in Canada,
with some 2 million doses of the Pfizer Inc/BioNTech SE
and Moderna Inc vaccines coming this week. The
United States said it is sharing 1.5 million doses of the
AstraZeneca vaccine with Canada as early as this week.

The U.S. National Institute of Allergy and Infectious
Diseases said on Monday that the independent monitoring board
charged with ensuring the safety and accuracy of AstraZeneca's
latest trial said the company may have given an incomplete view
of the shot's effectiveness. The company has since said it will
publish up-to-date results https://www.reuters.com/article/idUSKBN2BF1RE
from its latest trial within 48 hours.

"We will look at the complete data package (from the U.S.)
sometime in April, and will assess and communicate the results,"
said Supriya Sharma, chief medical adviser at Health Canada, the
federal health ministry. "The bottom line is that doesn't change
recommendations on the AstraZeneca vaccine at this time."

There will be a delay of a day or two on delivery of Moderna
vaccines this week, Alberta's chief medical officer of health
said, adding that bookings for shots will not be affected.

Canada also said it would give C$23.7 million ($18.9
million) to Ontario to open more voluntary isolation sites for
those who become infected with the virus and need a place to
quarantine as cases surge.

Saskatchewan's provincial government imposed new
restrictions in the city of Regina and surrounding area,
including a ban on private indoor gatherings, due to a spike in
infections caused by highly contagious new virus variants.

Quebec, which has avoided a third wave of infections, will
allow its older high school students to attend class daily
starting March 29.

Canada has recorded 940,000 virus infections and more than
22,700 deaths from COVID-19.

($1 = 1.2561 Canadian dollars)

(Reporting by Steve Scherer; Additional reporting by Rod Nickel
in Winnipeg and Allison Lampert in Montreal; Editing by Grant
McCool and Bill Berkrot)

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.